@prefix cas: <http://identifiers.org/cas/> .
@prefix dcterms1: <http://purl.org/dc/terms> .
@prefix inchikey: <http://identifiers.org/inchikey/> .
@prefix massbank: <https://identifiers.org/massbank/> .
@prefix mbo: <http://www.massbank.jp/ontology/> .
@prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> .
@prefix schema: <https://schema.org/> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

massbank:MSBNK-BAFG-CSL2311095957 a mbo:MassSpectrum ;
    dcterms1:creator "Kevin S. Jewell; Bj√∂rn Ehlig; Arne Wick" ;
    dcterms1:date "2023-11-09"^^xsd:date ;
    dcterms1:identifier "MSBNK-BAFG-CSL2311095957" ;
    dcterms1:license <https://creativecommons.org/licenses/by-sa/4.0/> ;
    dcterms1:rights "Copyright 2023 Federal Institute of Hydrology, Koblenz, Germany under dl-de/by-2-0" ;
    mbo:analytical_methods_and_conditions [ a mbo:AnalyticalMethods ;
            mbo:ac_instrument "TripleTOF 5600 SCIEX" ;
            mbo:collision_energy "110" ;
            mbo:column_name "Zorbax Eclipse Plus C18 2.1 mm x 150 mm, 3.5 um, Agilent" ;
            mbo:flow_gradient "0 min min 98% A, 1 min 98% A, 2 min 80% A, 16.5 min 2% A, 22 min 2% A, 22.1 min 98% A, 27 min 98% A" ;
            mbo:flow_rate "0.3 mL/min" ;
            mbo:fragmentation_mode "CID" ;
            mbo:instrument_type "LC-ESI-QTOF" ;
            mbo:ion_mode "POSITIVE" ;
            mbo:ms_type "MS2" ;
            mbo:retention_time "6.626 min" ;
            mbo:solvent "A: Water 0.1% Formic acid, B: Acetonitrile 0.1% Formic acid" ] ;
    mbo:compound [ a schema:chemicalsubstance ;
            mbo:ch_compound_class "Pharmaceutical; Metabolite" ;
            mbo:ch_exact_mass 2.411233e+02 ;
            rdfs:name "threo-Dihydrobupropion" ;
            rdfs:seeAlso cas:92264-82-9 ;
            schema:inChI "InChI=1S/C13H20ClNO/c1-9(15-13(2,3)4)12(16)10-6-5-7-11(14)8-10/h5-9,12,15-16H,1-4H3" ;
            schema:inChIKey inchikey:NDPTTXIBLSWNSF-UHFFFAOYSA-N ;
            schema:molecularFormula "C13H20ClNO" ;
            schema:name "threo-Dihydrobupropion" ;
            schema:smiles "CC(C(c1cccc(c1)Cl)O)NC(C)(C)C" ] ;
    mbo:has_peak [ mbo:intensity 1.1e+00 ;
            mbo:mz 4.2042e+01 ;
            mbo:peak_sequential_number 1 ;
            mbo:relative_intensity 64 ],
        [ mbo:intensity 2.2e+00 ;
            mbo:mz 7.50251e+01 ;
            mbo:peak_sequential_number 10 ;
            mbo:relative_intensity 128 ],
        [ mbo:intensity 9e-01 ;
            mbo:mz 7.70398e+01 ;
            mbo:peak_sequential_number 11 ;
            mbo:relative_intensity 52 ],
        [ mbo:intensity 6e-01 ;
            mbo:mz 8.70251e+01 ;
            mbo:peak_sequential_number 12 ;
            mbo:relative_intensity 35 ],
        [ mbo:intensity 1.47e+01 ;
            mbo:mz 8.904e+01 ;
            mbo:peak_sequential_number 13 ;
            mbo:relative_intensity 854 ],
        [ mbo:intensity 2.4e+00 ;
            mbo:mz 9.00475e+01 ;
            mbo:peak_sequential_number 14 ;
            mbo:relative_intensity 139 ],
        [ mbo:intensity 2.1e+00 ;
            mbo:mz 9.1056e+01 ;
            mbo:peak_sequential_number 15 ;
            mbo:relative_intensity 122 ],
        [ mbo:intensity 1.1e+00 ;
            mbo:mz 9.89995e+01 ;
            mbo:peak_sequential_number 16 ;
            mbo:relative_intensity 64 ],
        [ mbo:intensity 7e-01 ;
            mbo:mz 1.109992e+02 ;
            mbo:peak_sequential_number 17 ;
            mbo:relative_intensity 41 ],
        [ mbo:intensity 6e-01 ;
            mbo:mz 1.130402e+02 ;
            mbo:peak_sequential_number 18 ;
            mbo:relative_intensity 35 ],
        [ mbo:intensity 7e-01 ;
            mbo:mz 1.140462e+02 ;
            mbo:peak_sequential_number 19 ;
            mbo:relative_intensity 41 ],
        [ mbo:intensity 2.4e+00 ;
            mbo:mz 5.70761e+01 ;
            mbo:peak_sequential_number 2 ;
            mbo:relative_intensity 139 ],
        [ mbo:intensity 1.72e+01 ;
            mbo:mz 1.150537e+02 ;
            mbo:peak_sequential_number 20 ;
            mbo:relative_intensity 999 ],
        [ mbo:intensity 2e+00 ;
            mbo:mz 1.17057e+02 ;
            mbo:peak_sequential_number 21 ;
            mbo:relative_intensity 116 ],
        [ mbo:intensity 4e-01 ;
            mbo:mz 1.180666e+02 ;
            mbo:peak_sequential_number 22 ;
            mbo:relative_intensity 23 ],
        [ mbo:intensity 7e-01 ;
            mbo:mz 5.80686e+01 ;
            mbo:peak_sequential_number 3 ;
            mbo:relative_intensity 41 ],
        [ mbo:intensity 5e-01 ;
            mbo:mz 5.80829e+01 ;
            mbo:peak_sequential_number 4 ;
            mbo:relative_intensity 29 ],
        [ mbo:intensity 4e-01 ;
            mbo:mz 6.30549e+01 ;
            mbo:peak_sequential_number 5 ;
            mbo:relative_intensity 23 ],
        [ mbo:intensity 4.7e+00 ;
            mbo:mz 6.50423e+01 ;
            mbo:peak_sequential_number 6 ;
            mbo:relative_intensity 273 ],
        [ mbo:intensity 1.5e+00 ;
            mbo:mz 7.29856e+01 ;
            mbo:peak_sequential_number 7 ;
            mbo:relative_intensity 87 ],
        [ mbo:intensity 2e+00 ;
            mbo:mz 7.40191e+01 ;
            mbo:peak_sequential_number 8 ;
            mbo:relative_intensity 116 ],
        [ mbo:intensity 5e-01 ;
            mbo:mz 7.40335e+01 ;
            mbo:peak_sequential_number 9 ;
            mbo:relative_intensity 29 ] ;
    mbo:mass_spectram_meta_data [ a mbo:MassSpectramMetaData ;
            mbo:precursor_mz 2.421306e+02 ;
            mbo:precursor_type mbo:IT003 ] ;
    mbo:pk_num_peak 22 ;
    mbo:pk_splash "splash10-014r-9500000000-ec241ee10a6688231831" ;
    rdfs:comment "Acquisition method: 10.1002/rcm.8541" ;
    skos:definition "threo-Dihydrobupropion; LC-ESI-QTOF; MS2; 110 V" .

